In vitro inhibition of thrombin generation, after tissue factor pathway activation, by the oral, direct factor Xa inhibitor rivaroxaban

被引：130

作者：

Gerotziafas, G. T.

Elalamy, I.

Depasse, F.

Perzborn, E.

Samama, M. M.

机构：

[1] Univ Paris 06, Hop Tenon, Serv Hematol Biol, F-75020 Paris 20, France

[2] LCL Lab, Paris, France

[3] Bayer HealthCare, Cardiovasc Res, Wuppertal, Germany

[4] Hop Hotel Dieu, Serv Hematol Biol, F-75181 Paris, France

来源：

JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2007年 / 5卷 / 04期

关键词：

D O I：

10.1111/j.1538-7836.2007.02429.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：886 / 888

页数：4

共 10 条

[1] Agnelli G, 2006, EUR HEART J, V27, P761
[2] New anticoagulants: Anti IIa vs anti Xa - Is one better?
Bauer, KA
[J]. JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2006, 21 (01) : 67 - 72
[3] The inhibitory effect of melagatran, the active form of the oral direct thrombin inhibitor ximelagatran, compared with enoxaparin and r-hirudin on ex vivo thrombin generation in human plasma
Boström, SL
Hansson, GFH
Sarich, TC
Wolzt, M
[J]. THROMBOSIS RESEARCH, 2004, 113 (01) : 85 - 91
[4] Factor Xa is highly protected from antithrombin-fondaparinux and antithrombin-enoxaparin when incorporated into the prothrombinase complex
Brufatto, N
Ward, A
Nesheim, ME
[J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2003, 1 (06) : 1258 - 1263
[5] Oral, direct Factor Xa inhibition with BAY 59-7939 for the prevention of venous thromboembolism after total hip replacement
Eriksson, BI
Borris, L
Dahl, OE
Haas, S
Huisman, MV
Kakkar, AK
Misselwitz, F
Kälebo, P
[J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2006, 4 (01) : 121 - 128
[6] Towards a standardization of thrombin generation assessment: The influence of tissue factor, platelets and phospholipids concentration on the normal values of Thrombogram-Thrombinoscope assay
Gerotziafas G.T.
Depasse F.
Busson J.
Leflem L.
Elalamy I.
Samama M.M.
[J]. Thrombosis Journal, 3 (1)
[7] Comparison of the effect of fondaparinux and enoxaparin on thrombin generation during in-vitro clotting of whole blood and platelet-rich plasma
Gerotziafas, GT
Depasse, F
Chakroun, T
Van Dreden, P
Samama, MM
Elalamy, I
[J]. BLOOD COAGULATION & FIBRINOLYSIS, 2004, 15 (02) : 149 - 156
[8] Hemker HC, 2000, THROMB HAEMOSTASIS, V84, P747
[9] In vitro and in vivo studies of the novel antithrombotic agent BAY 59-7939 -: an oral, direct Factor Xa inhibitor
Perzborn, E
Strassburger, J
Wilmen, A
Pohlmann, J
Roehrig, S
Schlemmer, KH
Straub, A
[J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2005, 3 (03) : 514 - 521
[10] Prasa D, 1997, THROMB HAEMOSTASIS, V77, P498

← 1 →